Chemistry:Yttrium (90Y) tacatuzumab tetraxetan

From HandWiki
Revision as of 21:35, 5 February 2024 by NBrush (talk | contribs) (url)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Monoclonal antibody


Yttrium (90Y) tacatuzumab tetraxetan
Y-90 tacatuzumab tetraxetan structure.svg
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
Targetα-fetoprotein
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6470H9971N1712O2007S4290Y
Molar mass145 kg/mol
 ☒N☑Y (what is this?)  (verify)

Yttrium (90Y) tacatuzumab tetraxetan is an investigational humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.

References

  1. ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council". 4 September 2004. http://www.ama-assn.org/ama1/pub/upload/mm/365/yttrium_90_tacatuz.doc. 
  2. ↑ WHO Drug Information




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Yttrium_(90Y)_tacatuzumab_tetraxetan&oldid=3324915"